Skip to main content
. 2020 Oct 29;35(2):e23622. doi: 10.1002/jcla.23622

Figure 6.

Figure 6

The induction of HIF‐1α in the pro‐cancer effects of ANXA3 on melanoma. Cell growth (A), cell progression (B and C), cell migration (D and E), LDH activity and caspase‐3/9 activity levels (F‐H), HIF‐1α/VEGF expression (I‐K). Negative, negative group; si‐ANXA3, 50 ng of siANXA3 group; si‐ANXA3 + HIF‐1α, 50 ng of si‐ANXA3 group, and up‐regulation of HIF‐1α. **P < .01 versus negative group, *P < .01 versus 50 ng of ANXA3